New drug combo trial offers hope for Tough-to-Treat cancers

NCT ID NCT07070232

Recruiting now Disease control Sponsor: BioNTech SE Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called BNT326, both by itself and in combination with other cancer immunotherapies, for people with advanced solid tumors that have spread or returned after prior treatment. The main goals are to find the safest and most effective dose and to see how well the treatments work to control the cancer. It is enrolling adults with various advanced cancers, including melanoma, lung, breast, and cervical cancers.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Austin Health
RECRUITING

Heidelberg, Victoria, 3084, Australia
Beatson West of Scotland Cancer Centre
RECRUITING

Glasgow, G12 0YN, United Kingdom
Blacktown Hospital
RECRUITING

Blacktown, New South Wales, 2148, Australia
Cancer Research SA
RECRUITING

Adelaide, South Australia, 5000, Australia
Centre hospitalier universitaire de Liège
RECRUITING

Liège, 4000, Belgium
Centro Integral Oncologico Clara Campal
RECRUITING

Madrid, 28050, Spain
Charité - Campus Charité Mitte
NOT_YET_RECRUITING

Berlin, 10117, Germany
Cleveland Clinic Taussig Cancer Center
NOT_YET_RECRUITING

Cleveland, Ohio, 44195, United States
Dana Farber Cancer Institute
NOT_YET_RECRUITING

Boston, Massachusetts, 02215, United States
Duke Cancer Institute
NOT_YET_RECRUITING

Durham, North Carolina, 27710, United States
Florida Cancer Specialists
RECRUITING

Sarasota, Florida, 34232, United States
Fondazione IRCCS Istituto Nazionale dei Tumori
NOT_YET_RECRUITING

Milan, 20133, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITING

Roma, 00168, Italy
Hartford Healthcare
RECRUITING

Hartford, Connecticut, 06102, United States
Hospital Beata Maria Ana
RECRUITING

Madrid, 28007, Spain
Hospital Universitari Vall d'Hebron - VHIO
RECRUITING

Barcelona, 08035, Spain
Hospital Universitari i Politecnic La Fe
RECRUITING

Valencia, 46026, Spain
Hospital Universitario Fundacion Jimenez Diaz
RECRUITING

Madrid, 28040, Spain
Hospital Universitario Quironsalud Madrid
RECRUITING

Pozuelo de Alarcón, 28223, Spain
IEO Istituto Europeo di Oncologia
RECRUITING

Milan, 20141, Italy
Imperial College London
RECRUITING

London, W12 0HS, United Kingdom
Istituto Clinico Humanitas
RECRUITING

Rozzano, 20089, Italy
Istituto Nazionale Tumori Fondazione G. Pascale
RECRUITING

Naples, 80131, Italy
Klinikum der Universität München Campus Grosshadern
NOT_YET_RECRUITING

München, 81377, Germany
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02215, United States
Melanoma Institute Australia
RECRUITING

Wollstonecraft, New South Wales, 2065, Australia
Memorial Sloan Kettering Hospital
RECRUITING

New York, New York, 10065, United States
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612-9497, United States
Northern Centre for Cancer Care
RECRUITING

Newcastle upon Tyne, NE7 7DN, United Kingdom
One Clinical Research Pty Ltd
RECRUITING

Nedlands, Western Australia, 6009, Australia
Queen Elizabeth Hospital
RECRUITING

Birmingham, B15 2TH, United Kingdom
Royal Free Hospital
RECRUITING

London, NW3 2QG, United Kingdom
Royal Marsden Hospital
RECRUITING

Sutton, SM2 5PT, United Kingdom
Royal Marsden Hospital-London
RECRUITING

London, SW3 6JJ, United Kingdom
START Midwest, LLC
RECRUITING

Grand Rapids, Michigan, 49546, United States
START Mountain Region
RECRUITING

West Valley City, Utah, 84119, United States
South Texas Accelerated Research Therapeutics (START), LLC
RECRUITING

San Antonio, Texas, 78229, United States
Southampton General Hospital
RECRUITING

Southampton, SO16 6YD, United Kingdom
St Vincent's Hospital Sydney
RECRUITING

Darlinghurst, New South Wales, 2010, Australia
Tasman Oncology Research Ltd
RECRUITING

Southport, Queensland, 4215, Australia
The Alfred Hospital
RECRUITING

Melbourne, Victoria, 3004, Australia
The Board of Regents of the University of Wisconsin
RECRUITING

Madison, Wisconsin, 53792-6188, United States
The Christie Hospital
RECRUITING

Manchester, M20 4BX, United Kingdom
The Clatterbridge Cancer Centre
RECRUITING

Liverpool, L7 8YA, United Kingdom
The University of Texas MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Universitair Ziekenhuis Gent
RECRUITING

Ghent, 9000, Belgium
University College London Hospitals
RECRUITING

London, W1T 7HA, United Kingdom
University of California San Francisco
NOT_YET_RECRUITING

San Francisco, California, 94158, United States
Universitätsklinikum Tübingen
NOT_YET_RECRUITING

Tübingen, 72076, Germany
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
NOT_YET_RECRUITING

Mainz, 55131, Germany
Velindre Cancer Centre
RECRUITING

Cardiff, CF14 2TL, United Kingdom
Yale University
RECRUITING

New Haven, Connecticut, 06511, United States
Ziekenhuis Aan de Stroom ZAS vzw
RECRUITING

Wilrijk, 2610, Belgium

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMOR